Analyst Reports and Presentations

Analyst Reports and Presentations

               

Annual Reports

 
2012 Annual Report
 
2011 Annual Report
 
2010 Annual Report
 
2009 Annual Report
 
2009 Annual Report Excluding Financial Statements
 
2009 Annual Report Financial Statements

Company Presentations

 
Investor Presentation - May 2013
 
Investor Presentation
 
Investor Presentation Share Placement
 
2009 AGM Presentation
 
Investor Presentation to Wilson HTM

Analysts Reports *

 
Bioshares 15 February 2013
 
Heading Wilson HTM 19 Feb 2013 – Is Partner swapping desirable in USA?
 
Canaccord 7 February 2013 - Trophonification of the US
 
Bioshares February 2013
 
Bioshares 14 December 2012
 
Bioshares
 
Wilson HTM - Q1FY13 - Cut to Hold
 
Canaccord - Clean Up With NAN 09-Oct-2012
 
Select Equities - Initiation of Coverage 04-Sep-2012
 
Wilson HTM - Can Nan get GEHC moving?
 
Shaw Stockbroking - Biotech Market Wrap - June 2012
 
Wilson HTM - Capital raised - so let's see the sales
 
Shaw Research - Stand by your NAN
 
Wilson HTM - Q3 FY12
 
Wilson HTM - So Many Germs So Little Time
 
Linwar Securities - 1H12 result summary
 
Wilson HTM - 1HFY12 Results
 
Calendar 2012 shaping up nicely
 
Linwar Securities - Time to buy
 
Wilson HTM - Proceeding well, cash burn low
 
Shaw Research - Ramping up on all fronts
 
Growth Outlook Unchanged
 
Wilson HTM - Revenues ok, Margins not
 
Linwar Securities - Cash is King
 
Shaw Research - Idea of the Day
 
Wilson HTM - US Distribution Locked In
 
Shaw Research - Electrifying Distribution Agreement
 
Shaw Research - Trophon Re-Production
 
Wilson HTM - Re-Commence Commerical Production
 
Wilson HTM - Making Progress
 
Shaw Research - Not so Nano
 
Wilson HTM - Sales delay
 
Shaw Research - Big on demand
 
Wilson HTM - Capital raised on high demand
 
Wilson HTM – Sales boost
 
Shaw Research - Ramping up the rollout
 
Wilson HTM - FY09 Results
 
Shaw Research - Roll out the Trophon
 
Wilson HTM – Strong demand
 
Shaw Research - Nanosonics launches Trophon into Europe
 
Wilson HTM – FDA application filed
 
Shaw Research – Nanosonics Commences Sales
 
Wilson HTM – Sales Begin
 
Wilson HTM – Interim: Now for revenues
 
Wilson HTM – TGA Approval. FDA to follow?
 
Shaw Research – Off to a clean start
 
Wilson HTM – Sales to begin in 2009
 
Shaw Research – Nanosonics Ready to Roll
 
Wilson HTM – Upbeat Announcement
 
Wilson HTM – CEO Mark Granted
 
Wilson HTM – CE Mark soon but new CEO needed
 
Wilsons HTM – Progress Report
 
Wilsons HTM – Initiating Coverage Report

* Disclaimer

This information has been prepared by third parties and therefore Nanosonics makes no representations about the accuracy, reliability, completeness or timeliness of the Information. Nanosonics does not necessarily endorse or approve the recommendations, assumptions and conclusions contained in the information. The information does not constitute financial advice and should not be relied on as such. You should seek expert financial advice in relation to the information.